Results 171 to 180 of about 58,011 (261)

Risk of venous thromboembolism after SARS‐CoV‐2 vaccination—Evidence from genome‐wide association study and population‐based observational study

British Journal of Clinical Pharmacology, EarlyView.
Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind, Niclas Eriksson, Marco Cavalli, Yiyi Xu, Fredrik Nyberg, Anders Sundström, Mia Wadelius, Pär Hallberg   +7 more
wiley   +1 more source

Generative artificial intelligence in the publishing industry: adoption, use, intellectual property, and other challenges. [PDF]

Front Res Metr Anal
Giraldo-Barreto M.
europepmc   +1 more source

Awareness of the Black Triangle Scheme among healthcare professionals and consumers in Australia: A mixed‐methods study exploring reporting intentions and suggested improvements

British Journal of Clinical Pharmacology, EarlyView.
Aims The Black Triangle Scheme, introduced in 2018 in Australia, does not appear to have increased the quantity of adverse drug event (ADE) reports. This study evaluated healthcare professionals' (HCPs') and consumers' awareness of the scheme, its influence on intentions for future ADE reporting, and suggested improvements.
Eyob Alemayehu Gebreyohannes, Sieta T. de Vries, Mohammed Gebre Dedefo, Oliver Frank, Myra Thiessen, Lisa Kalisch Ellett, Christopher Thornton, Renly Lim   +7 more
wiley   +1 more source

Media portrayals of assisted suicide before, during, and after legalization changes: content analysis of the reporting in Austrian newspapers. [PDF]

Front Psychiatry
Pürcher P, Till B, Niederkrotenthaler T.   +2 more
europepmc   +1 more source

First‐in‐human, phase I, randomized, safety, pharmacokinetic, food‐effect and pharmacodynamic study of a tyrosine kinase 2/Janus kinase 1 inhibitor, SDC‐1801

British Journal of Clinical Pharmacology, EarlyView.
Aim The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), food‐effect (FE) and pharmacodynamics (PD) of an oral tyrosine kinase‐2 (TYK2)/Janus kinase‐1 (JAK1) inhibitor, SDC‐1801, in healthy adult participants. Methods This first‐in‐human study randomized 95 male and female participants.
Chris Brearley, Sam Francis, John Reader, Judi Proctor   +3 more
wiley   +1 more source

Medical device development and innovation for rare and pediatric populations: a global landscape overview. [PDF]

Orphanet J Rare Dis
Dooms M, O'Connor D, Melvin T, Mueller F, Peiris V, Pohlson K, Wong-Rieger D, Jonker AH, IRDiRC WG Medical Technologies for Rare Diseases.   +8 more
europepmc   +1 more source

Evaluating effectiveness of risk minimization through healthcare professional surveys: A review of post‐authorization studies, 2022–2024

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Risk minimization measures (RMMs) are key regulatory tools to ensure safe medicinal product use. Regulatory guidelines recommend pre‐specifying the targets, or ‘thresholds’, for assessing RMM effectiveness. We aimed to review recent industry‐sponsored post‐authorization safety studies (PASS) that evaluated the effectiveness of RMMs ...
Kexin Zhu, William A. Blumentals, Froilan G. Celzo, G. Caleb Alexander, Lingyun Zhou, Juhaeri Juhaeri, Corinne Jouquelet‐Royer, Jian‐Yu E   +7 more
wiley   +1 more source

Some topical issues of improving the Labor legislation of the Republic of Kazakhstan

BULLETIN of L.N. Gumilyov Eurasian National University. Law Series, 2019
openaire   +2 more sources

Chapter Topics: Librarians working with the legislative process can make a difference

College & Research Libraries News, 1991
Gail Junion-Metz, Ray E. Metz
openaire   +2 more sources

Public trust in AI-enabled telemedicine: affective, cognitive, and structural dimensions insights from multi-platform big data analytics. [PDF]

Front Med Technol
Binsar F, Hamsal M, Tenggono E, Abdurohman M, Hanafi R, Wahyudi I.   +5 more
europepmc   +1 more source